About Cann Group
Cann Group is a company based in Bundoora (Australia) founded in 2014. Cann Group has completed 1 acquisition, including Satipharm. Cann Group offers products and services including Medicinal Cannabis Products, Contract Manufacturing Services, and Research Partnerships. Cann Group operates in a competitive market with competitors including Bod Australia, among others.
- Headquarter Bundoora, Australia
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cann Group Limited
-
Annual Revenue
$7.47 M (USD)-26.49as on Jun 30, 2025
-
Net Profit
-$14.76 M (USD)56.39as on Jun 30, 2025
-
EBITDA
-$4.63 M (USD)57.42as on Jun 30, 2025
-
Latest Funding Round
$1.98 M (USD), Grant
Jul 03, 2020
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Cann Group
Cann Group is a publicly listed company on the ASX with ticker symbol CAN in Australia, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Cann Group
Cann Group offers a comprehensive portfolio of products and services, including Medicinal Cannabis Products, Contract Manufacturing Services, and Research Partnerships.
Develops cannabis for medical use to improve patient health outcomes.
Provides manufacturing for cannabis-related research and production.
Offers R&D collaborations for advancing cannabis therapeutics.
People of Cann Group
Unlock access to complete
Funding Insights of Cann Group
Investors in Cann Group
Cann Group has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Victorian Government.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Governance and public services for Victoria are administered.
|
Locked | Locked | Locked |
Investor details for Cann Group
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cann Group
Cann Group has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Satipharm.
Investment portfolio details for Cann Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cannabidiol supplements are manufactured and marketed by Satipharm.
|
Locked | Locked | 2011 | Locked |
Complete acquisition details for Cann Group
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Cann Group
Detailed financials for Cann Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cann Group Comparisons
Peer comparison for Cann Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cann Group
Cann Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bod Australia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medicinal cannabis products are manufactured by Bod Australia.
|
Detailed competitors of Cann Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cann Group
Complete news archive for Cann Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cann Group
Cann Group was founded in 2014 and raised its 1st funding round 6 years after it was founded.
Cann Group is headquartered in Bundoora, Australia. It is registered at Bundoora, Victoria, Australia.
Annual revenue of Cann Group is $7.47M as on Jun 30, 2025.
Cann Group was founded in 2014 and is based in Bundoora, Australia. Research services in the medical cannabis sector are offered by the company, focusing on cannabinoid development and therapeutic applications. Operations include cultivation, extraction, and clinical research within the pharmaceutical and biotechnology industries. Services are tailored for medical and research purposes, supporting innovation in cannabis-based treatments across Australia.
Cann Group's top competitors include Bod Australia.
Cann Group offers Medicinal Cannabis Products, Contract Manufacturing Services, and Research Partnerships.
Yes, Cann Group is publicly traded on ASX under the ticker symbol CAN.
Cann Group has made 1 acquisition, including Satipharm.
Cann Group has 1 investor. Key investors include Victorian Government.
The ticker symbol of Cann Group is CAN on ASX.